Tuğba Önder (T Önder)

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Epidermal Growth Factor Receptor

Palliative Care

Top Venues

International journal of clinical oncology

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

This page only lists publications with an associated author ORCID identifier.

Publications

Tuğba Önder, Cengiz Karaçin
Trastuzumab-induced optic neuritis: "blindness" side effect. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2024)
Tuğba Önder, Cengiz Karaçin
Effect of HER2-low status on brain metastasis-free survival and survival after brain metastasis in patients with breast cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
Tuğba Önder, Ö Ateş, I Öner, C Karaçin
Relationship between HER2-low status and efficacy of CDK4/6 inhibitors in advanced breast cancer: a real-world study. International journal of clinical oncology 29 (7) (2024)
Tuğba Önder, Ö Ateş, I Öner, C Karaçin
Relationship between HER2-low status and efficacy of CDK4/6 inhibitors in advanced breast cancer: a real-world study. International journal of clinical oncology 29 (7) (2024)
Tuğba Önder, Ö Ateş, I Öner, C Karaçin
Relationship between HER2-low status and efficacy of CDK4/6 inhibitors in advanced breast cancer: a real-world study. International journal of clinical oncology (2024)